Abstract
Background: Emerging evidence indicates that microRNA (miRNA)-related genetic polymorphisms are strongly involved in the post-transcriptional regulation of the expression of pharmacokinetics and pharmacodynamics- related genes, therefore contributing to the genetic variability of drug response.
Objective: To investigate the associations of miRNA-related genetic polymorphisms, including miRNA-5189 rs562929801, miRNA-595 rs4909237, SLCO1A2 rs4149009 and MTHFR rs3737966, and clinical response to methotrexate in Chinese rheumatoid arthritis patients.
Methods: One hundred patients treated with MTX for approximately 3 months were prospectively followed up to evaluate the clinical response according to European League Against Rheumatism (EULAR) good and moderate response, disease activity score in 28 joint counts - erythrocyte sedimentation rate (DAS28-ESR) low disease activity (LDA) and remission (REM), change in DAS28-ESR (ΔDAS28-ESR) and ΔDAS28-ESR > 0.6. Genetic polymorphisms were genotyped utilizing the HI-SNP technology.
Results: Of the 100 patients with a mean age of 52.23 ± 12.71 years, 81 patients were female (81.00%). After adjusting potential confounders, the major allele of miRNA-5189 rs562929801 was found to be significantly associated with EULAR response (A/A + A/G versus G/G, RR = 0.81, 95% CI = 0.67-0.99, P = 0.04) and ΔDAS28-ESR > 0.6 under dominant model (A/A + A/G versus G/G, RR = 0.83, 95% CI = 0.71-0.98, P = 0.03). However, nonsignificant evidence was detected for the remaining three miRNA-related genetic polymorphisms in neither univariable analysis nor multivariable analysis.
Conclusion: Our results indicated that miRNA-5189 rs562929801 was significantly associated with clinical response to MTX, and this association warrants further replication studies with larger sample sizes.
[http://dx.doi.org/10.1016/S0140-6736(17)31491-5] [PMID: 28612748]
[http://dx.doi.org/10.1002/art.41752] [PMID: 34101376]
[http://dx.doi.org/10.1136/annrheumdis-2019-216655] [PMID: 31969328]
[http://dx.doi.org/10.1111/1756-185X.13513] [PMID: 30809944]
[http://dx.doi.org/10.1136/rmdopen-2019-000993] [PMID: 31413870]
[http://dx.doi.org/10.1136/bmj.i1777] [PMID: 27102806]
[http://dx.doi.org/10.1002/art.22353] [PMID: 17139662]
[http://dx.doi.org/10.1016/j.jbspin.2019.03.008] [PMID: 30928534]
[http://dx.doi.org/10.1007/s10067-019-04600-7] [PMID: 31161488]
[http://dx.doi.org/10.1016/S0140-6736(19)31276-0] [PMID: 31395440]
[http://dx.doi.org/10.2217/pgs-2019-0121] [PMID: 31648623]
[http://dx.doi.org/10.2217/pgs-2019-0089] [PMID: 31559917]
[http://dx.doi.org/10.1016/bs.apha.2018.02.003] [PMID: 29801581]
[http://dx.doi.org/10.3389/fcell.2017.00086] [PMID: 29018797]
[http://dx.doi.org/10.1016/j.cell.2009.01.002] [PMID: 19167326]
[http://dx.doi.org/10.1097/FPC.0000000000000245] [PMID: 27649261]
[http://dx.doi.org/10.1016/j.leukres.2018.01.004] [PMID: 29306656]
[http://dx.doi.org/10.1002/jgm.2990] [PMID: 28990296]
[http://dx.doi.org/10.2147/PGPM.S350417] [PMID: 35437350]
[http://dx.doi.org/10.1002/art.1780310302] [PMID: 3358796]
[http://dx.doi.org/10.1002/art.27584] [PMID: 20872595]
[http://dx.doi.org/10.1002/art.1780380107] [PMID: 7818570]
[http://dx.doi.org/10.1002/art.1780390105] [PMID: 8546736]
[http://dx.doi.org/10.1098/rsob.170019] [PMID: 28381629]
[http://dx.doi.org/10.1089/gtmb.2018.0226] [PMID: 30758239]
[http://dx.doi.org/10.1080/21655979.2022.2045844] [PMID: 35246006]
[http://dx.doi.org/10.1158/1078-0432.CCR-12-2080] [PMID: 23243220]
[http://dx.doi.org/10.2174/1381612820666140825123632] [PMID: 25163739]
[http://dx.doi.org/10.1002/jbt.22513] [PMID: 32304147]
[http://dx.doi.org/10.2174/1389200219666171227201047] [PMID: 29283070]